LEADER 01471nas  22005053  450 
001 9910139074303321
005 20230120011401.0
011   $a2324-8645
035   $a(OCoLC)811339257
035   $a(CKB)2560000000094607
035   $a(CONSER)--2012203464
035   $a(EXLCZ)992560000000094607
100   $a20120928a20139999  ---            a
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aHuman gene therapy$iClinical development
210  1$aNew Rochelle, NY :$cMary Ann Liebert,$d2013-
215   $a1 online resource
311   $a2324-8637 
517 3 $aHuman gene therapy clinical development
531   $aHUMAN GENE THERAPY
531   $aHUM GENE THER CLIN DEV
531 0 $aHum. gene ther., Clin. dev.
606   $aGene therapy$vPeriodicals
606   $aCellular therapy$vPeriodicals
606   $aGenetic Therapy
606   $aDrug Discovery
606   $aCellular therapy$2fast$3(OCoLC)fst00850322
606   $aGene therapy$2fast$3(OCoLC)fst00939638
608   $aPeriodical.
608   $aPeriodicals.$2fast
615  0$aGene therapy
615  0$aCellular therapy
615 12$aGenetic Therapy.
615 22$aDrug Discovery.
615  7$aCellular therapy.
615  7$aGene therapy.
676   $a615.895
906   $aJOURNAL
912   $a9910139074303321
996   $aHuman gene therapy$9796346
997   $aUNINA